Skip to main content
. Author manuscript; available in PMC: 2020 Jun 9.
Published in final edited form as: Mol Cancer Ther. 2009 Jul 7;8(7):2007–2014. doi: 10.1158/1535-7163.MCT-09-0336

Figure 2. The antiproliferative activity of PM00104 is not influenced by the XPD-NER status.

Figure 2.

Cells were exposed to the indicated concentrations of Et743 or PM00104 for 72 hours and analyzed by MTT assay. Open symbols correspond to the NER-deficient XPD cells and filled symbols to the XPD-complemented counterpart, XPD-c. Squares and circles represent Et743 and PM00104, respectively.